SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-012129
Filing Date
2022-05-12
Accepted
2022-05-12 16:10:33
Documents
43
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbla20220331_10q.htm   iXBRL 10-Q 488279
2 EXHIBIT 31.1 ex_371496.htm EX-31.1 13622
3 EXHIBIT 31.2 ex_371497.htm EX-31.2 13705
4 EXHIBIT 32.1 ex_371498.htm EX-32.1 4863
5 EXHIBIT 32.2 ex_371499.htm EX-32.2 5072
  Complete submission text file 0001437749-22-012129.txt   2615729

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbla-20220331.xsd EX-101.SCH 26644
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20220331_cal.xml EX-101.CAL 18828
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20220331_def.xml EX-101.DEF 169178
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20220331_lab.xml EX-101.LAB 168392
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20220331_pre.xml EX-101.PRE 185363
37 EXTRACTED XBRL INSTANCE DOCUMENT pbla20220331_10q_htm.xml XML 321771
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 22917893
SIC: 2834 Pharmaceutical Preparations